Ampio Pharmaceuticals Navigation
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Overview
    • About Ampion
    • What Makes Ampion Different?
    • Inflammatory Joint Disease
    • Inflammatory Lung Diseases, COVID-19
    • Inflammatory Kidney Diseases
    • Rare Inflammatory Pediatric Diseases
  • Manufacturing
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
  • About Us
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • Overview
    • About Ampion
    • What Makes Ampion Different?
    • Inflammatory Joint Disease
    • Inflammatory Lung Diseases, COVID-19
    • Inflammatory Kidney Diseases
    • Rare Inflammatory Pediatric Diseases
  • Manufacturing
  • Investors
    • Stock Information
    • Financial Filings
    • Corporate Governance
    • Presentations & Media
  • News
    • Latest News
    • Publications
  • Contact Us
Home Investors Presentations & Media

Presentations & Media

Ampio – Management Presentation 2021

Audio Recording of the Q1 2021 Earnings Call on May 5, 2021

Ampio Pharmaceuticals’ Presentation at the Benzinga Biotech Small Cap Conference held virtually on March 24 & 25, 2021

David Bar-Or

How Ampion Can be Used to Treat COVID-19

An interview with Dr. David Bar-Or, MD   December 16, 2020

Audio Recording of the Ampio Annual Investor Meeting held on Saturday, December 12, 2020

Audio Recording of the Q3 2020 Earnings Call on November 5, 2020

Real Time Quote

SUBSCRIBE

Get email notifications of the latest Ampio news.

Latest News

Ampio Pharmaceuticals, Inc. to Report Fiscal 2021 Second Quarter Financial Results and Provide Corporate Business Update

July 14, 2021

Ampio Pharmaceuticals Announces Patient Randomization and Dosing in AP-019 Phase II Study of Inhaled Ampion in COVID-19 Respiratory Distress

June 25, 2021

Ampio Pharmaceuticals, Inc. to Join the Russell 2000® Index and Russell 3000® Index

June 18, 2021
member-logo-85

Twitter icon

© 2021 Ampio Pharmaceuticals Inc.

373 Inverness Parkway, Suite 200
Englewood, CO 80112 USA

Privacy Policy

Main office: +1 720 437 6500
Fax: +1 720 437 6501

General email inquiries: info@ampiopharma.com

  • Home
  • About Us
  • Pipeline
  • Manufacturing
  • Investors
  • News
  • Contact Us